ClinicalTrials.Veeva

Menu

A Single Center Proof Of Concept Study To Assess Intra And Perioperative Safety Profile Of OMNI Surgical System

M

Mark Gallardo, MD

Status

Unknown

Conditions

Open Angle Glaucoma

Treatments

Device: OMNI Surgical System

Study type

Interventional

Funder types

Other

Identifiers

NCT04530084
1290569

Details and patient eligibility

About

The overall objective of this study is to determine the safety and usability of OMNI surgical system in performing canaloplasty and trabeculotomy. Outcome measures will include 1) adverse events (intraoperative and perioperative) 2) BCVA 3) Secondary surgical interventions 4) mean IOP and 5) mean number of hypotensive medications

Enrollment

30 estimated patients

Sex

All

Ages

22+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Male or female subjects, 22 years or older.
  2. Visually significant cataract or pseudophakic with a posterior chamber intraocular lens (PCIOL)
  3. Diagnosed with open angle glaucoma (e.g. primary open angle glaucoma, pigmentary glaucoma, pseudoexfoliative glaucoma)
  4. Scheduled for canaloplasty and trabeculotomy

Exclusion criteria

  1. Any other intraocular surgery at the time of canaloplasty and trabeculotomy excepting cataract surgery for those subjects with cataract.
  2. Prior trabeculectomy, other bleb-forming glaucoma surgery (e.g. tube shunt), or implanted trabecular bypass stents.
  3. Any other ocular pathologies that may interfere with the study procedure or be exacerbated by the OMNI procedure.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

Diagnosed with open angle glaucoma
Experimental group
Treatment:
Device: OMNI Surgical System

Trial contacts and locations

1

Loading...

Central trial contact

Mark Gallardo, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems